This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haiman, C. A. Articles by Henderson, B. E. Search for Related Content PubMed PubMed Citation Articles by Haiman, C. A. Articles by Henderson, B. E.

Genetic Variation in Angiotensin I-Converting Enzyme (ACE) and Breast Cancer Risk

The Multiethnic Cohort¹

Departments of Preventive Medicine [C. A. H., S. O. H., P. B., B. E. H.] and Emergency Medicine [S. O. H.], University of Southern California, Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California 90089, and Cancer Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813 [L. N. K.]

The A-240T and I/D polymorphisms in the angiotensin I-converting enzyme (ACE) gene are markers of circulating ACE levels and have been associated with numerous cardiovascular disease outcomes. More recently, the low-activity A and I alleles at these polymorphic sites have been inversely related with breast cancer risk. We assessed the relationship between the A-240T and I/D ACE variants and breast cancer risk in a case-control analysis (n = 1263 cases with invasive breast cancer and 2269 controls) among African-American, Japanese, Latina, and white women in the Multiethnic Cohort Study. Odds ratios and 95% confidence intervals are presented adjusted for established breast cancer risk factors. Among all women combined, we observed no significant association between the A-240T polymorphism and breast cancer risk. For the I/D polymorphism, contrary to expectation, women with the I/I genotype had a marginally significant increase in breast cancer risk (versus DD genotype: odds ratio, 1.30; 95% confidence interval, 1.05–1.61), although associations were not entirely consistent across ethnic groups. These data do not support the hypothesis that women with lower ACE levels, as predicted by the low-activity A and I ACE alleles, are at reduced risk of breast cancer. Overall, these results suggest that the A-240T and I/D ACE polymorphisms are not likely to be strong predictors of breast cancer risk.

This article has been cited by other articles:

				S. A. Alves Correa, S. M. Ribeiro de Noronha, N. C. Nogueira-de-Souza, C. Valleta de Carvalho, A. M. Massad Costa, J. Juvenal Linhares, M. T. Vieira Gomes, and I. D. C. Guerreiro da Silva Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women Journal of Renin-Angiotensin-Aldosterone System, March 1, 2009; 10(1): 51 - 58. [Abstract] [PDF]

				D. Rosskopf and M. C. Michel Pharmacogenomics of G Protein-Coupled Receptor Ligands in Cardiovascular Medicine Pharmacol. Rev., December 1, 2008; 60(4): 513 - 535. [Abstract] [Full Text] [PDF]

				M. Sugimoto, T. Furuta, N. Shirai, M. Ikuma, H. Sugimura, and A. Hishida Influences of chymase and Angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1929 - 1934. [Abstract] [Full Text] [PDF]

				M. P.A. Ebert, U. Lendeckel, S. Westphal, J. Dierkes, J. Glas, C. Folwaczny, A. Roessner, M. Stolte, P. Malfertheiner, and C. Rocken The Angiotensin I-Converting Enzyme Gene Insertion/Deletion Polymorphism Is Linked to Early Gastric Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2987 - 2989. [Abstract] [Full Text] [PDF]

				A. M. Gonzalez-Zuloeta Ladd, A. Arias Vasquez, F. A. Sayed-Tabatabaei, J.W. Coebergh, A. Hofman, O. Njajou, B. Stricker, and C. van Duijn Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2143 - 2146. [Abstract] [Full Text] [PDF]

				C. Rocken, U. Lendeckel, J. Dierkes, S. Westphal, S. Carl-McGrath, B. Peters, S. Kruger, P. Malfertheiner, A. Roessner, and M. P.A. Ebert The Number of Lymph Node Metastases in Gastric Cancer Correlates with the Angiotensin I-Converting Enzyme Gene Insertion/Deletion Polymorphism Clin. Cancer Res., April 1, 2005; 11(7): 2526 - 2530. [Abstract] [Full Text] [PDF]

				W.-P. Koh, J.-M. Yuan, D. Van Den Berg, H.-P. Lee, and M. C. Yu Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore Carcinogenesis, February 1, 2005; 26(2): 459 - 464. [Abstract] [Full Text] [PDF]

				H. Katzov, A. M. Bennet, P. Kehoe, B. Wiman, M. Gatz, K. Blennow, B. Lenhard, N. L. Pedersen, U. de Faire, and J. A. Prince A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity Hum. Mol. Genet., November 1, 2004; 13(21): 2647 - 2657. [Abstract] [Full Text] [PDF]